2. Rupel E., Brown R. Nephroscopy with removal of stone following nephrostomy for obstructive calculous anuria. J Urol. 1941;47:177–182.

3. Григорьев Н.А., Семенякин И.В., Малхасян В.А., Гаджиев Н.К. Мочекаменная болезнь. Урология. 2016;Приложение:37–70.

4. Türk C., Petřík A., Sarica K., Seitz C., Skolarikos A., Straub M., Knoll T. EAU Guidelineson Interventional Treatment for Urolithiasis. Eur. Urol. 2016:69(3):475–482.

5. Osman M., Wendt-Nordahl G., Heger K., Michel M.S., Alken P., Knoll T. Percutaneous nephrolithotomywith ultrasonography-guided renalaccess: experience from over 300 cases. BJU Int. 2005;96:875–878.

6. Michel M.S., Trojan L., Rassweiler J.J. Complications in percutaneous nephrolithotomy. Eur Urol. 2007;51:899–906.

7. Labate G., Modi P., Timoney A., Cormio L., Zhang X., Louie M., Grabe M. The Percutaneous Nephrolithotomy Global Study: Classification of Complications. Journal of Endourology. 2011;25(8):1275–1280.

8. de la Rosette J., Assimos D., Desai M., Gutierrez J., Lingeman J., Scarpa R., Tefekli A. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol. 2011;25(1):11–17.

9. Seitz C., Desai M., Häcker A., Hakenberg O.W., Liatsikos E., Nagele U., Tolley D. Incidence, Prevention, and Management of Complications Following Percutaneous Nephrolitholapaxy. European Urology. 2012;61(1):146–158.

10. Tefekli A., Kurtoglu H., Tepeler K., Karadag M.A., Kandirali E., Sari E., Baykal M., Muslumanoglu A.Y. Does the metabolic syndrome or its components affect the outcome of percutaneous nephrolithotomy? J Endourol. 2008;22:35–40.

11. Duvdevani M., Razvi H., Sofer M., Beiko D.T., Nott L., Chew B.H., Denstedt J.D. Third prize: contemporary percutaneous nephrolithotripsy: 1585 procedures in 1338 consecutive patients. J Endourol. 2007;21(8):824–829.

12. Kreydin E.I., Eisner B.H. Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol. 2013;10(10):598–605.

13. Sharifi Aghdas F., Akhavizadegan H., Aryanpoor A., Inanloo H., Karbakhsh M. Fever after percutaneous nephrolithotomy:contributing factors. Surg Infect. 2006;7:367.

14. Mariappan P., Smith G., Moussa S.A., Tolley D.A. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int. 2006;98:1075–1079.

15. Doğan H.S., Sahin A., Cetinkaya Y., Akdoğan B., Ozden E., Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol. 2002;16(9):649–653.

16. Gutierrez J., Smith A., Geavlete P., Shah H., Kural A.R., de Sio M., Amón Sesmero J.H., Hoznek A., de la Rosette J. Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol. 2013;31(5):1135–1140.

17. Lojanapiwat B., Kitirattrakarn P. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. UrolInt. 2011;86:448–52.

18. Mariappan P., Smith G., Bariol S.V., Moussa S.A., Tolley D.A. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol. 2005;173:1610.

19. Mariappan P., Loong C.W. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol. 2004;171:2142–2145.

20. Yang M.G., Zheng Z.D., Xu Z.Q., Lin H.L., Zhuang Z.M., Zhang C.X. Prophylactic antibiotic use in percutaneous nephrolithotomy: a meta-analysis. Zhonghua Wai Ke Za Zhi. 2013;51(10):922–927.

21. Gravas S., Montanari E., Geavlete P., Onal B., Skolarikos A., Pearle M., Sun Y.H., de la Rosette J. Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J. Urol. 2012;188:843.

22. Tuzel E. et al. B Prospective comparative study of two protocols of antibiotic prophylaxis in percutaneous nephrolithotomy. J Endourol. 2013;27(2):172–176.

23. Hsieh C.H., Yang S.S., Lin C.D., Chang S.J. Are prophylactic antibiotics necessary in patients with preoperative sterile urine undergoing ureterorenoscopic lithotripsy? BJU Int. 2014;113:275.

24. El-Nahas A.R., Shokeir A.A., El-Assmy A.M., Mohsen T., Shoma A.M., Eraky I., El-Kenawy M.R., El-Kappany H.A. Post-Percutaneous Nephrolithotomy Extensive Hemorrhage: A Study of Risk Factors. The Journal of Urology. 2007;177(2):576–579.

25. Galek L., Darewicz B., Werel T., Darewicz J. Haemorrhagic Complications of Percutaneous Lithotripsy: Original Methods of Treatment. International Urology and Nephrology. 2000;32(2):231–233.

26. Michel M.S., TrojanL., RassweilerJ.J. Complications in percutaneous nephrolithotomy. Eur Urol. 2007;51:899–906.

27. El-Assmy A.M., Shokeir A.A., Mohsen T., El-Tabey N., El-Nahas A.R., Shoma A.M., Eraky I., El-Kenawy M.R., El-Kappany H.A. Renal access by urologist or radiologist for percutaneous nephrolithotomy-is it still an issue? J Urol. 2007;178:916–920.

28. Ziaee S.A., Karami H., Aminsharifi A., Mehrabi S., Zand S., Javaherforooshzadeh A. One-stage tract dilation for percutaneous nephrolithotomy: is it justified? JEndourol. 2007;21:1415–1420.

29. Semins M.J., Bartik L., Chew B.H., Hyams E.S., Humphreys M., Miller N.L., Shah O., Paterson R.F., Matlaga B.R. Multicenter analysis of postoperative CT findings after percutaneous nephrolithotomy: defining complication rates Urology. 2011;78(2):291–294.

30. Turna B., Nazli O., DemiryoguranS. et al. Percutaneousnephrolithotomy: Variables thatinfluence hemorrhage. Urology. 2007;69:603–607.

31. Yamaguchi A., Skolarikos A., Buchholz N.P., Chomón G.B., Grasso M., Saba P., Nakada S., de la Rosette J. Clinical Research Office Of The Endourological Society Percutaneous Nephrolithotomy Study Group. Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study J Endourol. 2011;25(6):933–939.

32. Muslumanoglu A.Y., Tefekli A., Karadag M.A., Tok A., Sari E., Berberoglu Y. Impact of percutaneous access point number and location on complication and success rates in percutaneous nephrolithotomy. Urol Int. 2006;77:340–346.

33. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130.

34. Payne D.A., Hayes P.D., Jones C.I., Belham P., Naylor A.R., Goodall A.H. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg. 2002;35:1204.

35. Lee K.L., Stoller M.L. Minimizing and managing bleeding after percutaneous nephrolithotomy. Curr OpinUrol. 2007;17:120–124.

36. Yuan S., Ferrell C., Chandler W.L. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res. 2007;120:29–37.

37. Rossini R., Bramucci E., Castiglioni B., De Servi S., Lettieri C., Lettino M., Musumeci G., Visconti L.O., Piccaluga E., Savonitto S., Trabattoni D., Buffoli F., Angiolillo D.J., Bovenzi F., Cremonesi A., Scherillo M., Guagliumi G. Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation. G Ital Cardiol (Rome). 2012;13(7–8):528–551.

38. Rastinehad A.R., Andonian S., Smith A.D., Siegel D.N. Management of Hemorrhagic Complications Associated with Percutaneous Nephrolithotomy. Journal of Endourology. 2009;1763–1767.

39. Kyriazis I. et al. Complications in Percutaneous Nephrolithotomy. World Journal of Urology. 2015;33(8):1069–1077.

40. Keoghane S.R., Cetti R.J., Rogers A.E., Walmsley B.H. Blood Transfusion, Embolisation and Nephrectomy after Percutaneous Nephrolithotomy (PCNL). BJU International. 2013;111(4): 628–632.

41. Jinga V., Dorobat B., Youssef S., Radavoi G.D., Braticevici B., Filipoiu F., Balgradean M. Transarterial Embolization of Renal Vascular Lesions after Percutaneous Nephrolithotomy. Chirurgia. 2013;108(4):521–529.

42. Bookstein J.J., Ernst C.B./ Vasodilatory and Vasoconstrictive Pharmacoangiographic Manipulation of Renal Collateral Flow. Radiology. 1973;108(1):55–59.

43. Kessaris D.N., Bellman G.C., Pardalidis N.P., Smith A.G. Management of hemorrhage after percutaneous renal surgery. J Urol. 1995;153(3):604–608.

44. Richstone L. Management of Hemorrhage after Percutaneous Renal Surgery. Journal of Endourology. 2008;22(6):1129–1136.

45. Li L., Zhang Y., Chen Y., Zhu K.S., Chen D.J., Zeng X.Q., Wang X.B. A Multicentre Retrospective Study of Transcatheter Angiographic Embolization in the Treatment of Delayed Haemorrhage after Percutaneous Nephrolithotomy. European Radiology. 2015;25(4):1140–1147.

46. Ramaswamy R.S., Akinwande O., Tiwari T. Renal Embolization: Current Recommendations and Rationale for Clinical Practice. Curr. Urol. Rep. 2018;19(3):5. Doi: 10.1007/s11934-018-0756-5.

47. Mauro М.А., Murphy K.P.J, Thomson K.R, Venbrux A.C., Morgan R.A. Image-Guided Interventions, 2nd Edition-Expert Radiology Series (Expert Consult – Online and Print). Elsiver. 2014;424. ISBN 9781455705962.

48. el-Nahas A.R., Shokeir A.A., Mohsen T., Gad H., el-Assmy A.M., el-Diasty T., el-Kappany H.A. Functional and morphological effects of postpercutaneous nephrolithotomy superselective renal angiographic embolization. Urology. 2008;71(3):408–412.

49. Aminsharifi A., Irani D., Eslahi A. Massive Hemorrhage after Percutaneous Nephrolithotomy: Saving the Kidney When Angioembolization Has Failed or Is Unavailable. International Journal of Surgery. 2014;12(8):872–876.

50. Michel M.S., Trojan L., Rassweiler J.J. Complications in percutaneousnephrolithotomy. Eur Urol. 2007;51(4):899–906.

51. Munver R., Delvecchio F.C., Newman G.E., Preminger G.M. Critical analysis of supracostal access for percutaneous renal surgery. J Urol. 2001;166:1242–1246.

52. Lojanapiwat B., Prasopsuk S. Upper-pole access for percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches. J Endourol. 2006;20(7):491–494.

53. Shah H.N., Hegde S.S., Mahajan A.P., Sodha H., Shah R., Bansal M. Splenic injury: rare complication of percutaneous nephrolithotomy: report of two cases with review of literature. J Endourol. 2007;21:919–922.

54. El-Nahas A.R., Mansour A.M., Ellaithy R., Abol-Enein H. Case report: conservative treatment of liver injury during percutaneous nephrolithotomy. J Endourol. 2008;22:1649–1652.

55. Traxer O. Management of injury to the bowel during percutaneous stone removal. Endourol. 2009.

56. Sherman J.L., Hopper K.D., Greene A.J., Johns T.T. The retrorenal colon on computed tomography: a normal variant. J Comput Assist Tomogr. 1985;9(2):339–341.

57. Hopper K.D., Sherman J.L., Luethke J.M., Ghaed N. The retrorenal colon in the supine and prone patient. Radiology. 1987;162(2):443–446.